Automation + Miniaturization = Acceleration
Automation + Miniaturization = Acceleration
raises the institutional and
research profile of UPOL
develops innovative chemistry for:
  • unmet medical needs
  • materials and nanotechnologies of the future
  • sustainable agriculture

Innovative Chemistry Group

The Innovative Chemistry group will be established on the basis of the ERA Chairs grant awarded within the Horizon Europe ERA Chairs Call. During the course of the next five years, CATRIN will be implementing an absolutely unique project entitled ACCELERATOR, the aim of which is to bring together the world-renowned professor, inventor and innovator, Alexander Dömling, as the ERA Chair, and CATRIN’s all three divisions, merging them into a unique scientific ecosystem.

Alexander Dömling

Alexander Dömling is a world-renowned scientist in the fields of miniaturization, synthetic chemistry automation and multicomponent reaction chemistry. In the first decade of his professional life, which he refers to as his “ learning period“, he studied chemistry and biology at the Technical University of Munich. He received his doctorate from the world-renowned scientist Ivar Ugi. Thanks to the support of the Humboldt Foundation, he spent his postdoctoral period with two-time Nobel laureate Barry Sharpless at the Scripps Research Institute in California. After returning from the US, he founded his first biotechnology company, Morphochem.


Project information

Project Duration
1 February 2023–31 January 2028
Total Cost
2 499 062 EUR
EU Contribution
2 499 062 EUR